Industry: Healthcare | Publish Date: 12-Mar-2020 | No of Pages: 228 | No. of Tables: 125 | No. of Figures: 105 | Format: PDF | Report Code : N/A
The Global Implantable Cardiac Monitor Market was valued at USD 521.41 million in 2019 and is predicted to reach USD 1 billion by 2030 with a CAGR of 6.1% from 2020-2030.
The implantable cardiac monitor is also known as the implantable loop recorder. These are small devices that can be inserted into the human body for continuously monitoring their heart beats. They have the ability to not only monitor but also to evaluate and report the inconsistent and unexplained arrhythmias. The increasing prevalence of cardiac arrhythmias such as atrial fibrillation and bradycardia has boosted the demand for implantable cardiac monitor market globally.
The implantable cardiac monitor eliminates the need for bulky external monitors that require inconvenient wire leads attached to the patient. Technological advancements in cardiac monitor devices have made them easier to be implanted under the skin of the patient’s chest for continuously monitoring their heart and detect cardiac arrhythmias and atrial fibrillation.
Increasing incidences of atrial fibrillation, myocardial infarction, and arrhythmias have been driving the growth of global implantable cardiac monitor market. Also, factors such as durability of implantable cardiac monitors along with other advantages they offer such as reduced duration of hospitalization and lesser readmission requirements are contributing to the growth of this market.
Moreover, investments made by the key players in the R&D to innovate such devices are also supporting the growth of implantable cardiac monitor market. However, the availability of alternative modes of treatments and high cost associated with implantable monitors are hampering the growth of this market to some extent. On the other hand, increased awareness about the advantages of these devices is expected to create new opportunities for market players in the coming future.
The implantable cardiac monitor market is segmented into indication, end user and geography. On the basis of indication, the market is segmented into cardiac arrhythmias, atrial fibrillation, epilepsy and unexplained falls. On the basis of end user, the market is segmented into hospitals, cardiac centers & clinics, and ambulatory surgery centers. Based on geography the market is segmented into North America, Europe, Asia Pacific and RoW.
The North American region is anticipated to hold the lion share of the market during the forecast period. This is attributable to the factors including high adoption rate of technologically advanced implantable cardiac monitors, the presence of major key healthcare companies, high consumer awareness, and favorable reimbursement framework.
However, Asia Pacific region is expected to show rapid and consistent growth in terms of market share within the forecast period owing to factors such as increasing prevalence of atrial fibrillation, rise in obesity, and growing geriatric population.
Lucrative growth opportunities make the implantable cardiac monitor market extremely competitive. Some of the major players in the market are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation and Phoenix Heart Center. Strategic alliances, acquisitions and innovations along with R&D are key strategies used by the market players to maintain market dominance.
The implantable cardiac monitor report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on
The study comprises a deep dive analysis of the implantable cardiac monitor market trend including the current and future trends for depicting the prevalent investment pockets in the market
The information related to key drivers, restraints and opportunities and their impact on the implantable cardiac monitor market is provided in the report.
The market share of the players in the global implantable cardiac monitor market along with their competitive analysis.
Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.
Cardiac Arrhythmias
Atrial Fibrillation
Epilepsy & Unexplained Falls
Hospitals
Cardiac Centers & Clinics
Ambulatory Surgical Centers
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Malaysia
New Zealand
Rest of Asia-Pacific
RoW
Brazil
South Africa
Egypt
Remaining Countries
REPORT SCOPE AND SEGMENTATION:
Parameters |
Details |
Analysis Period |
2019–2030 |
Base Year Considered |
2020 |
Forecast Period |
2020–2030 |
Market Size Estimation |
Billion (USD) |
Market Segmentation |
By Indication (Cardiac Arrhythmias, Atrial Fibrillation, Epilepsy & Unexplained Falls) By End User (Hospitals, Cardiac Centers & Clinics, Ambulatory Surgical Centers (ASCs) |
Geographical Segmentation |
North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Spain, Switzerland, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Malaysia, New Zealand, Rest of APAC), Rest of the World (Brazil, South Africa, Egypt, Remaining Countries) |
Companies Profiled |
Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation and Phoenix Heart Center |
KEY PLAYERS
Abbott Laboratories
Biotronik SE & Co. KG
Boston Scientific Corporation
Edwards Lifescience Corporation
General Electric Company
Koninklijke Philips N.V.
LivaNova PLC
Medtronic plc
Nihon Kohden Corporation
Phoenix Heart Center